Coronavirus Latest News

BioNTech on track to become first foreign Covid-19 vaccine approved for use in mainland China

A Chinese advisory panel has given the green light to the Covid-19 vaccine developed by BioNTech, meaning it will become the first vaccine developed overseas to be used on the mainland once it receives approval from the drug regulator.If the National Medical Products Administration acts on the panel’s advice, the jabs – made under the brand name Comirnaty – will also become the first vaccine using cutting-edge mRNA technology to be made available in the mainland.Wu Yifang, chief executive of…

Read the original article at South China Morning Post

Related Articles

Back to top button